ALGO on Cboe Canada | OHCFF on OTCQB | 0HC on Frankfurt
A Billion ReasonsThis AI StartupIs in Full-On
Light AI is turning your smartphone into a medical lab, delivering lab-grade diagnostics for infections like Strep A with 97% accuracy. And it's doing it faster, cheaper, and smarter than anything out there.
97% Accuracy
Lab-grade diagnostics right from your smartphone
Instant Results
Diagnose in seconds, not hours or days
FDA Submission
Anticipated to begin in late 2025
“Every year, over 600 million people worldwide contract Group A Streptococcus (Strep A), an infection that was once shrugged off as a minor inconvenience but now increasingly spirals into devastating outcomes.”
World Health Organization
Global Health Authority
Strep A Diagnosis
Tap to analyze throat image with our advanced AI algorithm
Instant Results
Analysis in seconds
97% Accuracy
Lab-grade diagnostics
600M+
Strep A Cases Yearly
$1T
Economic Impact by 2050
97%
Diagnostic Accuracy
$293B
mHealth Market by 2030
The Fever Dream NIGHTMARE
A global health crisis with hundreds of millions of lives and hundreds of billions of dollars at stake
2:34 AM
It's 2:34 AM. You wake suddenly...
You wake suddenly from what feels like a nightmare—but the pounding in your head, chills racing down your spine, and fiery pain in your throat tell you instantly: this is no dream. You're sick.
Instinctively, you reach for your phone, fingers trembling. Because when you're this sick, what's your first move? You Google it. Your bloodshot eyes meet the screen as it unlocks, and you quickly type your symptoms. What you read next doesn't just amplify your anxiety—it sends your worry into overdrive:
"Strep A Resurgence: A Silent Killer Strikes."
Your pulse spikes as terrifying headlines flood the screen. Group A Streptococcus (Strep A)—once thought to be little more than a routine sore throat—is surging globally.
Global Health Crisis
Scarlet fever cases have exploded, with over 27,000 infections reported recently in the UK alone, more than doubling previous records.
Even worse, severe invasive cases (iGAS) have tragically claimed the lives of dozens of young children, overwhelming hospitals and terrifying parents.
Deadly Consequences
This isn't the sore throat you shrugged off as a child. Scarlet fever, left unchecked, can permanently damage your heart, destroy kidneys, or even turn deadly.
With antibiotics losing effectiveness and healthcare systems buckling under pressure, every fever, rash, or cough feels like a gamble you can't afford.
Economic Impact
Infectious diseases and antibiotic resistance are projected to drain the world economy by as much as $1 trillion annually by 2050 due to healthcare expenses and lost productivity.
Already, unnecessary antibiotic prescriptions from delayed or incorrect diagnoses cost the U.S. healthcare system more than $3 billion every year.
"Now imagine if the phone you're clutching right now could cut through the fear and uncertainty—delivering instant, accurate answers through a simple scan, precisely when you need them most."
How much would that clarity be worth to you in this exact moment?
The Crisis is Real— But the Solution Isn't a Fantasy
It's already in your hand, right now, pulsing through the world's most ubiquitous device: the smartphone.
Your Phone, Your Lifeline
Light AI's patented platform uses AI to analyze throat images captured by your smartphone camera
Key Benefits
No extra hardware needed
Results in seconds, not days
97% accuracy rate
100% negative predictive value
As reliable as traditional tests
Why This Solution Matters Now
Speed Saves Lives
Traditional lab diagnostics take hours—even days—far too long when invasive infections (like Strep A's deadly iGAS) can escalate in mere hours. Smartphone-based AI solutions can accurately diagnose illnesses in seconds, turning panic into immediate action.
And it's not stopping at Strep A
Plans are in motion to tackle skin conditions, eye disorders, and more—turning your phone into a one-stop health hub.
7.3 Billion
Smartphones already in pockets worldwide
$293 Billion
mHealth market by 2030
$164 Billion
AI healthcare market explosion
This is Not Just a "Theory"
Smartphone-based diagnostics already have proven themselves to be potentially profitable and transformative
AliveCor (KardiaMobile)
Turned smartphones into FDA-approved ECG monitors for detecting heart irregularities
Valuation Growth
100x gain for early investorsFrom $10 million in 2011 to over $1 billion by 2021
Impact: Millions of devices sold, major partnerships formed, and a revolutionary impact on mobile cardiac care
"A modest $1,000 investment could have soared to $100,000, demonstrating the extraordinary upside of smartphone-powered diagnostics."
Butterfly Network (iQ Ultrasound)
Created a handheld ultrasound device connecting directly to smartphones
Valuation Growth
10x leap in under four yearsFrom $125 million in 2017 to over $1.25 billion by 2021
Impact: Used by medical professionals across 20+ countries, reshaping how portable diagnostic imaging is done globally
"A modest $1,000 investment could have soared to $10,000, demonstrating the extraordinary upside of smartphone-powered diagnostics."
These Successes aren't Flukes—they're Blueprints
The smartphone diagnostics revolution is already creating impressive growth stories in the public markets
Hims & Hers Health (HIMS)
+400%A multi-specialty telehealth platform connecting consumers directly to healthcare professionals through smartphone apps and web-based telemedicine
Why It Took Off: Explosive revenue growth (+94% in 2022), rapid adoption of telehealth services, expansion into popular categories like GLP-1 weight loss treatments, and a path to profitability
LifeMD, Inc. (LFMD)
+500%A direct-to-consumer telehealth provider offering virtual healthcare, concierge medicine, and treatment plans via digital platforms and smartphone apps
Why It Took Off: Launching a highly successful telehealth-based weight management program, reporting quarterly revenue growth rates of 60-90% year-over-year, achieving positive EBITDA
iCAD, Inc. (ICAD)
+180%Specialists in AI-based medical imaging diagnostics, particularly cancer detection, using advanced algorithms to improve accuracy and speed of diagnoses
Why It Took Off: A strategic AI partnership with Google Health, FDA clearances for next-generation AI products, and surging demand for AI diagnostic solutions in healthcare
These real-world examples demonstrate the possible investment potential and market excitement surrounding smartphone-based telehealth and AI diagnostics.
The next AI giant in healthcare diagnostics could be emerging right now.
Meet Light AI: The Maverick Ready to Rewrite Healthcare
Here's why Light AI is the next big thing in healthcare—and why savvy investors are paying attention
The Problem: A $1 Trillion Crisis
600 million people get Strep A every year
$1 trillion in economic damage from infectious diseases by 2050
$3 billion wasted yearly in the U.S. on misdiagnoses
Hospitals are drowning, antibiotics are failing, and millions lack access to basic diagnostics
It's a perfect storm—and Light AI is the lightning rod.
The Solution: Your Phone, Your Lifeline
Light AI's patented platform uses AI to analyze throat images captured by your smartphone camera
No extra hardware, no lab visits—just a quick scan and results in seconds
97% accuracy and a 100% negative predictive value
Plans to expand to skin conditions, eye disorders, and more—turning your phone into a one-stop health hub
As reliable as traditional tests but infinitely faster and more accessible.
Light AI vs. Traditional Diagnostics
| Feature | Light AI | Traditional Methods | Advantage |
|---|---|---|---|
| Diagnostic Speed | Seconds | Hours to Days | Light AI |
| Accuracy | 97% | 90-95% | Light AI |
| Accessibility | Anywhere with a smartphone | Requires lab/clinic visit | Light AI |
| Cost | Fraction of traditional tests | $50-200 per test | Light AI |
| Scalability | Global, instant deployment | Limited by physical infrastructure | Light AI |
Why Now? Timing Is Everything
7.3B
Smartphones already in pockets worldwide
$293B
mHealth market by 2030
$164B
AI healthcare market explosion
Light AI is riding two trends—smartphones and AI—at the exact moment they're reshaping healthcare.
The Playbook: Patents, Pilots, and Partnerships
This isn't a "wait and see" story—it's a "get in now" opportunity
Patents Locked In
With a library of 300,000+ images and proprietary AI, Light AI's tech is protected and battle-tested.
FDA Submission in late 2025
FDA submission process is anticipated to start in late 2025.
MrBeast Boost
A partnership with Beast Philanthropy is anticipated to deliver 10,000 tests to Africa, amplifying visibility and impact.
Emerging Market Push
Pilots anticipated in African countries to stimulate future scalability.
The Numbers: A Ground-Floor Opportunity
Financial Overview
IPO
Currently trading below $1.00 per share on all exchanges, Light AI (Cboe Canada: ALGO, OTCQB: OHCFF; FSE: 0HC) began trading publicly in January 2025.
Market Cap
At current prices, Light AI is valued around $48 million USD (approx. USD $68–70 million CAD), indicative of its early-stage status and potential upside as milestones are met.
Cash Runway
After raising roughly $18.5 million CAD (approx. USD $12.9 million USD) from its IPO, the company has a projected runway through the majority of 2025 to fund enhanced product development and related initial commercialization initiatives.
Compare that to peers like Hims & Hers (HIMS) with +250%, LifeMD (LFMD) +500%, or iCAD (+100%), each of which leveraged telehealth and AI diagnostics to deliver significant investor returns. Light AI, with its breakthrough technology and similar potential, could be the next in line for explosive growth.
The Risks: Know the Game
Regulatory Approval
FDA and global approvals are essential but not guaranteed; delays or challenges could impact timelines and valuations.
Market Adoption
Winning over clinicians and patients is crucial—though the MrBeast partnership has already shown strong consumer validation potential.
Competition
Larger competitors could enter the market, but Light AI's early patents and data collection provide a robust defensive moat.
Financial Execution
Pre-revenue status means careful cash management is critical, but the current cash runway and experienced CFO provide comfort.
But Here's the Thing:
Every disruptor faces risks. The ones who win big—like AliveCor and Butterfly—turn challenges into fuel.
The Bottom Line: Light AI isn't just another startup
It's a potential healthcare revolution in your pocket. With a massive potential market, a patented solution, and a path to scale!
The AI Healthcare Revolution Is Here — Got Questions? Ask A.I.B.E. Now.
This article was disseminated on behalf of Light AI Inc. The information contained herein is for informational purposes only and is not investment advice. Please consult with a financial advisor before making any investment decisions.